Haemonetics Corporation booked $1.3B in FY2026 revenue, contracting 2.0% year over year — slower than 63% of Healthcare companies we track, at a 7.3% net margin.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.